Dhrita Khatri
Overview
Explore the profile of Dhrita Khatri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moore C, Williams E, Dyas R, Halman A, Stenta T, Khatri D, et al.
Clin Transl Sci
. 2025 Feb;
18(2):e70108.
PMID: 39899439
5-hydroxytryptamine-3 (5-HT) receptor antagonists including ondansetron, tropisetron, dolasetron, palonosetron, granisetron, and ramosetron are commonly used to prevent and treat nausea and vomiting. Most of these medications are at least partially...
2.
Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D
Clin Pharmacol Ther
. 2024 Sep;
117(1):106-115.
PMID: 39345195
Psychedelics have recently re-emerged as potential treatments for various psychiatric conditions that impose major public health costs and for which current treatment options have limited efficacy. At the same time,...
3.
Khatri D, Felmingham B, Moore C, Lazaraki S, Stenta T, Collier L, et al.
Br J Clin Pharmacol
. 2024 Aug;
90(11):2724-2741.
PMID: 39147586
Tacrolimus, a calcineurin inhibitor, is a highly effective immunosuppressant used in solid organ transplantation (SOT). However, it is characterized by a narrow therapeutic range and high inter-patient variability in pharmacokinetics....
4.
Conyers R, Halman A, Moore C, Stenta T, Felmingham B, Collier L, et al.
BMJ Open
. 2024 May;
14(5):e085115.
PMID: 38760050
Introduction: DNA-informed prescribing (termed pharmacogenomics, PGx) is the epitome of personalised medicine. Despite international guidelines existing, its implementation in paediatric oncology remains sparse. Methods And Analysis: Minimising Adverse Drug Reactions...